Checkpoint Inhibition Causing Complete Remission of Metastatic Combined Hepatocellular-Cholangiocarcinoma after Hepatic Resection

Combined hepatocellular-cholangiocarcinoma (CHC) is a rare type of primary liver cancer, speculated to arise from hepatic progenitor cells, and with a worse prognosis than hepatocellular carcinoma (HCC). Serum alpha-fetoprotein (AFP) levels may be one prognostic factor. It has been suggested that ch...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Magnus Rizell, Fredrik Åberg, Mats Perman, Lars Ny, Liselotte Stén, Farida Hashimi, Joar Svanvik, Per Lindnér
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Karger Publishers 2020-04-01
श्रृंखला:	Case Reports in Oncology
विषय:	checkpoint inhibition combined hepatocellular-cholangiocarcinoma sorafenib immune-related hepatitis
ऑनलाइन पहुंच:	https://www.karger.com/Article/FullText/507320
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!